share_log

太龙药业(600222.SH):8月公司未实施股份回购

Henan Taloph Pharmaceutical Stock (600222.SH): The company did not implement share repurchase in August.

Gelonghui Finance ·  Sep 2 04:27

As of August 2024, Henan Taloph Pharmaceutical Stock (600222.SH) announced that the company did not implement any share repurchases. As of August 31, 2024, the company has repurchased a total of 4,693,600 shares, accounting for 0.82% of the total share capital of the company. The highest price of the repurchase transaction was 4.97 yuan/share, and the lowest price was 3.82 yuan/share. The total amount paid was 21,274,189.00 yuan (excluding transaction costs). The repurchase of the shares mentioned above complies with the relevant laws and regulations and the requirements of the company's share repurchase program.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment